Pansib, Bb Boy S.

HRN: 21-26-92  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/25/2022
07/01/2022
IV
32mg
Q24Hrs
Tc Neonatal Pneumonia
Waiting Final Action 
06/25/2022
AMPICILLIN 250MG (VIAL)
06/25/2022
07/01/2022
IV
105mg
Q12Hrs
Tc Neonatal Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: